Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial
| dc.contributor.author | Yun, Sergi | |
| dc.contributor.author | Comín Colet, J. | |
| dc.contributor.author | Calero Molina, Esther | |
| dc.contributor.author | Hidalgo, Encarnación | |
| dc.contributor.author | José Bazán, Núria | |
| dc.contributor.author | Cobo Marcos, Marta | |
| dc.contributor.author | Soria, Teresa | |
| dc.contributor.author | Llácer, Pau | |
| dc.contributor.author | Fernández, Cristina | |
| dc.contributor.author | García Pinilla, José Manuel | |
| dc.contributor.author | Cruzado, Concepción | |
| dc.contributor.author | Juan Bagudá, Javier de | |
| dc.contributor.author | Et.al. | |
| dc.date.accessioned | 2025-10-14T07:51:08Z | |
| dc.date.available | 2025-10-14T07:51:08Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | he potential of mobile health (mHealth) technology combining telemonitoring and teleintervention as a non-invasive intervention to reduce the risk of cardiovascular events in patients with heart failure during the early post-discharge period (ie, the vulnerable phase) has not been evaluated to our knowledge. We investigated the efficacy of incorporating mHealth into routine heart failure management in vulnerable-phase patients. | |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 24.1 Q1 JCR 2024 | spa |
| dc.description.impact | 6.838 Q1 SJR 2024 | spa |
| dc.description.impact | No data IDR 2023 | spa |
| dc.description.sponsorship | Novartis | |
| dc.identifier.citation | Yun, S., Comín-Colet, J., Calero-Molina, E., Hidalgo, E., José-Bazán, N., Cobo Marcos, M., Soria, T., Llàcer, P., Fernández, C., García-Pinilla, J. M., Cruzado, C., González-Franco, Á., García-Marina, E. M., Morales-Rull, J. L., Solé, C., García-Romero, E., Núñez, J., Civera, J., Fernández, C., … Fernández, J. (2025). Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (Hermes): A multicentre, randomised controlled trial. The Lancet Digital Health, 7(5), 100866. https://doi.org/10.1016/j.landig.2025.02.006 | |
| dc.identifier.doi | 10.1016/j.landig.2025.02.006 | |
| dc.identifier.issn | 2589-7500 | |
| dc.identifier.uri | https://hdl.handle.net/11268/16390 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | http://doi.org/10.1016/j.landig.2025.02.006 | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject.other | Telemedicina | |
| dc.subject.other | Infarto del Miocardio | |
| dc.subject.other | Ensayo Clínico Controlado Aleatorio | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Sistema cardiovascular | |
| dc.subject.unesco | Investigación médica | |
| dc.title | Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 713e6276-e112-4373-8760-aa719af244e3 | |
| relation.isAuthorOfPublication.latestForDiscovery | 713e6276-e112-4373-8760-aa719af244e3 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Evaluation of mobile health technology combining telemonitoring and teleintervention_2025.pdf
- Size:
- 251.51 KB
- Format:
- Adobe Portable Document Format

